Expression levels of (A) IDO1 and (B) TGF-β1 were measured from vaginal swab samples of women who were Chlamydia positive at first visit (time point 0), cleared their infection after azithromycin treatment, and were invited for follow up visits (1–4 months post infection clearance). Here, IDO1 is linked to infection.